Merix Bioscience is a biotechnology company that researches and develops cancer vaccines. An investment analyst for a venture capital fund must evaluate whether or not to recommend participation in a second round of financing for the company. The analyst must assess the company's strengths and weaknesses, the value of shares and determine the key clauses of the term sheet.
